
This episode features expert guidance on the application of emerging evidence in immunotherapy and precision-based approaches for colorectal cancer treatment.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TPJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027. Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on I mmunotherapy and M olecular, P recision-Based A pproaches in C RC T reatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This educational activity is supported through medical education grants from Bristol Myers Squibb, Exelixis, Inc…
Host: PVI, PeerView Institute for Medical Education
Guest: Scott Kopetz, MD, PhD, FACP
Bristol Myers Squibb, Exelixis, Inc., Johnson & Johnson, Taiho Oncology, Inc.
Organizations: Colorectal Cancer Alliance
Explore listener stats, chart rankings, contacts and more on the PeerView Gastroenterology CME/CNE/CPE Video Podcast podcast page.